NO2252275T3 - - Google Patents

Info

Publication number
NO2252275T3
NO2252275T3 NO09709833A NO09709833A NO2252275T3 NO 2252275 T3 NO2252275 T3 NO 2252275T3 NO 09709833 A NO09709833 A NO 09709833A NO 09709833 A NO09709833 A NO 09709833A NO 2252275 T3 NO2252275 T3 NO 2252275T3
Authority
NO
Norway
Application number
NO09709833A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NO2252275T3 publication Critical patent/NO2252275T3/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO09709833A 2008-02-13 2009-02-13 NO2252275T3 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2821808P 2008-02-13 2008-02-13
PCT/US2009/034162 WO2009103035A2 (en) 2008-02-13 2009-02-13 Templated open flocs of anisotropic particles for enhanced pulmonary delivery

Publications (1)

Publication Number Publication Date
NO2252275T3 true NO2252275T3 (pt) 2018-04-28

Family

ID=40955349

Family Applications (1)

Application Number Title Priority Date Filing Date
NO09709833A NO2252275T3 (pt) 2008-02-13 2009-02-13

Country Status (7)

Country Link
US (6) US20090208582A1 (pt)
EP (1) EP2252275B1 (pt)
AU (1) AU2009214443B2 (pt)
CA (1) CA2723314C (pt)
DK (1) DK2252275T3 (pt)
NO (1) NO2252275T3 (pt)
WO (1) WO2009103035A2 (pt)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2723314C (en) * 2008-02-13 2017-01-10 The Board Of Regents, The University Of Texas System Templated open flocs of anisotropic particles for enhanced pulmonary delivery
PT2410981T (pt) 2009-03-26 2017-05-25 Pulmatrix Inc Formulações em pó seco e métodos para tratar doenças pulmonares
US8506799B2 (en) * 2009-09-09 2013-08-13 ClearCorp Suspended particle characterization system for a water processing facility
US9248110B2 (en) 2010-03-18 2016-02-02 Steven Lehrer Compositions and methods of treating and preventing lung cancer and lymphangioleiomyomatosis
WO2011115988A1 (en) * 2010-03-18 2011-09-22 Steven Lehrer Compositions and methods of treating and preventing lung cancer
US9228785B2 (en) 2010-05-04 2016-01-05 Alexander Poltorak Fractal heat transfer device
WO2012030647A1 (en) 2010-08-30 2012-03-08 Pulmatrix, Inc. Treatment of cystic fibrosis using calcium lactate, leucine and sodium chloride in a respiraple dry powder
US9061352B2 (en) 2010-08-30 2015-06-23 Pulmatrix, Inc. Dry powder formulations and methods for treating pulmonary diseases
IL286573B (en) 2010-09-29 2022-08-01 Pulmatrix Operating Co Inc Monovalent metallic cation dry powders for inhalation
WO2012050945A1 (en) 2010-09-29 2012-04-19 Pulmatrix, Inc. Cationic dry powders
WO2014186754A2 (en) 2013-05-16 2014-11-20 Board Of Regents The University Of Texas System Dry solid aluminum adjuvant-containing vaccines and related methods thereof
CN104274426A (zh) * 2013-07-03 2015-01-14 陆克塞纳医药公司 昂丹司琼细粉、昂丹司琼气溶胶组合物及其用途
CN104274427A (zh) * 2013-07-03 2015-01-14 陆克塞纳医药公司 格拉司琼气溶胶组合物及其用途
EP3738592B1 (en) * 2013-10-08 2022-01-26 AI Therapeutics, Inc. Rapamycin for the treatment of lymphangioleiomyomatosis
DK3107548T3 (da) 2014-02-20 2022-07-18 Otitopic Inc Tørpulverformuleringer til inhalation
EP4218742A1 (en) 2014-04-04 2023-08-02 AI Therapeutics, Inc. An inhalable rapamycin formulation for treating age-related conditions
EP3179986B1 (en) 2014-07-31 2023-03-15 Vectura Inc. Dry powder formulations for inhalation
AU2015330905B2 (en) 2014-10-07 2021-02-25 AI Therapeutics, Inc. An inhalable rapamycin formulation for the treatment of pulmonary hypertension
CN107666903B (zh) * 2015-05-01 2021-08-20 得克萨斯州大学系统董事会 多药脆性基质组合物
PE20181295A1 (es) 2015-09-01 2018-08-07 First Wave Bio Inc Metodos y composiciones para tratar afecciones asociadas a una respuesta inflamatoria anomala
US10550019B2 (en) 2016-04-08 2020-02-04 OptikTechnik LLC Automated dosing system and method with light profiling for wastewater filtration system
WO2018013668A1 (en) 2016-07-12 2018-01-18 Alexander Poltorak System and method for maintaining efficiency of a heat sink
CA3039485A1 (en) 2016-10-14 2018-04-19 Pulmatrix Operating Company, Inc. Antifungal dry powders
US11918646B2 (en) 2017-12-11 2024-03-05 Board Of Regents, The University Of Texas System Dry adjuvanted immune stimulating compositions and use thereof for mucosal administration
WO2019204568A1 (en) * 2018-04-20 2019-10-24 Board Of Regents, The University Of Texas System Apparatus and methods for characterizing plume geometry
US10980756B1 (en) 2020-03-16 2021-04-20 First Wave Bio, Inc. Methods of treatment
WO2021188564A1 (en) 2020-03-16 2021-09-23 First Wave Bio, Inc. Methods of treating covid-19 with a niclosamide compound
EP4125923A1 (en) 2020-04-01 2023-02-08 Board of Regents, The University of Texas System Pharmaceutical compositions of niclosamide
CN116710118A (zh) 2020-05-26 2023-09-05 格兰达利斯有限公司 病毒性呼吸道感染的治疗方法
WO2022055817A1 (en) 2020-09-09 2022-03-17 Gradalis, Inc. Composition formulated into inhalable dosage forms for the treatment of lung|tumors
EP4337173A1 (en) 2021-05-12 2024-03-20 TFF Pharmaceuticals, Inc. Dry powder formulations of tacrolimus for administration by inhalation once daily (qd)
WO2023034795A1 (en) * 2021-08-30 2023-03-09 Board Of Regents, The University Of Texas System Monoclonal antibody dry powders
US20230112800A1 (en) 2021-08-31 2023-04-13 Board Of Regents, The University Of Texas System Delayed release niclosamide formulation
WO2024059819A2 (en) 2022-09-15 2024-03-21 Tff Pharmaceuticals, Inc. Compositions of cannabinoids for delivery by inhalation

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9501841D0 (en) 1995-01-31 1995-03-22 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
JPH1112197A (ja) 1997-06-18 1999-01-19 Cosmo Sogo Kenkyusho:Kk 悪性腫瘍診断剤及び治療剤
US6565885B1 (en) * 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6284282B1 (en) * 1998-04-29 2001-09-04 Genentech, Inc. Method of spray freeze drying proteins for pharmaceutical administration
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6585957B1 (en) * 2000-01-25 2003-07-01 Aeropharm Technology Incorporated Medicinal aerosol formulation
TWI224515B (en) 2000-06-23 2004-12-01 Norton Healthcare Ltd Pre-metered dose magazine for breath-actuated dry powder inhaler
JP2003146523A (ja) 2001-11-15 2003-05-21 Canon Inc 画像形成装置
CA2483218C (en) * 2002-04-25 2012-07-10 Nektar Therapeutics Uk Ltd Particulate materials
GB0216562D0 (en) * 2002-04-25 2002-08-28 Bradford Particle Design Ltd Particulate materials
CN1694689A (zh) * 2002-09-30 2005-11-09 阿库斯菲尔公司 供吸入的缓释多孔微粒
JP2006513235A (ja) * 2002-12-31 2006-04-20 ネクター セラピューティクス 真菌感染症療法のためのエアゾール化可能な医薬製剤
US9175906B2 (en) 2003-01-15 2015-11-03 Board Of Regents, The University Of Texas System Drug particles from freezing onto a surface
JP2007505136A (ja) * 2003-09-10 2007-03-08 マツプ・フアーマシユーテイカルズ・インコーポレーテツド ジヒドロエルゴタミンを肺吸入により体循環に送達するためのエアゾール製剤
US9061027B2 (en) 2004-08-27 2015-06-23 Board Of Regents, The University Of Texas System Enhanced delivery of drug compositions to treat life threatening infections
MX2009012782A (es) * 2007-05-25 2010-03-04 Univ British Columbia Formulaciones para administracion oral de agentes terapeuticos y metodos relacionados.
CA2723314C (en) * 2008-02-13 2017-01-10 The Board Of Regents, The University Of Texas System Templated open flocs of anisotropic particles for enhanced pulmonary delivery

Also Published As

Publication number Publication date
US20210007971A1 (en) 2021-01-14
EP2252275B1 (en) 2017-11-29
US11364197B2 (en) 2022-06-21
US10434062B2 (en) 2019-10-08
EP2252275A2 (en) 2010-11-24
WO2009103035A2 (en) 2009-08-20
AU2009214443B2 (en) 2013-10-10
US20220354778A1 (en) 2022-11-10
CA2723314C (en) 2017-01-10
US10660850B2 (en) 2020-05-26
EP2252275A4 (en) 2013-11-06
CA2723314A1 (en) 2009-08-20
DK2252275T3 (en) 2018-03-05
US20100221343A1 (en) 2010-09-02
US10092512B2 (en) 2018-10-09
WO2009103035A3 (en) 2009-11-12
US20190117557A1 (en) 2019-04-25
US20090208582A1 (en) 2009-08-20
US12029816B2 (en) 2024-07-09
US20200069572A1 (en) 2020-03-05
AU2009214443A1 (en) 2009-08-20

Similar Documents

Publication Publication Date Title
BRPI0917573A2 (pt)
BRPI0918697A2 (pt)
BRPI0920750A2 (pt)
BRPI0919470A2 (pt)
BRPI0922455A2 (pt)
BRPI0907698A2 (pt)
BRPI0917618A8 (pt)
BRPI0923734A2 (pt)
NO2252275T3 (pt)
BRPI0922669A2 (pt)
BRPI0908120A2 (pt)
BRPI0904541A8 (pt)
BRPI0919811A2 (pt)
BRPI0920914A2 (pt)
BRPI0922550A2 (pt)
BRPI0913605A2 (pt)
CH2352018H2 (pt)
AR073287B1 (pt)
BRPI0919477A2 (pt)
BRPI0923127A (pt)
BRPI0923137A2 (pt)
BRMU8803485U8 (pt)
CN300871218S (zh) 标贴(5)
CN300890432S (zh) 袜子(x0812)
CN300856086S (zh) 网络摄像机